Autor: |
Corredoira, Juan, Miguez, Enrique, Mateo, Lara María, Fernández-Rodríguez, Ricardo, García-Rodríguez, José Francisco, Pérez-González, Alexandre, Sanjurjo, Ana, Pulian, María Victoria, Ayuso-García, Blanca, In behalf all members of GESBOGA group, Serrano, M., Jove, M. J., Alonso, P., Justo, E., Piñeiro, J. C., Alonso, M. P., García-Garrote, F., Coira, M. A., Blanco, A., Gómez-Méndez, R. |
Předmět: |
|
Zdroj: |
European Journal of Clinical Microbiology & Infectious Diseases; Jul2023, Vol. 42 Issue 7, p907-912, 6p |
Abstrakt: |
Whether cirrhotic patients with Streptococcus bovis bacteremia have an increased risk of colorectal neoplasm is uncertain. A multicentric retrospective cohort study was conducted investigating associations between S. bovis biotype and species, cirrhosis, and colorectal neoplasm. Out of 779 patients with S. bovis bacteremia, 69 (8.7%) had cirrhosis. No differences were found in the prevalence of colorectal neoplasm between cirrhotic and non-cirrhotic patients undergoing colonoscopy. Among cirrhotic patients, prevalence of colorectal neoplasms was higher in S. bovis biotype I (S. gallolyticus) bacteremia (80%) than in S. bovis biotype II (33.3%; p < 0.007). In conclusion, risk of colorectal neoplasm is high among cirrhotic patients with S. gallolyticus bacteremia. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|